Compare TARA & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | PESI |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 208.1M |
| IPO Year | 2014 | 1996 |
| Metric | TARA | PESI |
|---|---|---|
| Price | $3.97 | $16.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $24.40 | N/A |
| AVG Volume (30 Days) | 464.4K | ★ 494.2K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.25 | ★ 43.61 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,948,000.00 | $642,000.00 |
| Revenue This Year | N/A | $34.62 |
| Revenue Next Year | N/A | $77.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.97 | $8.14 |
| 52 Week High | $7.82 | $18.40 |
| Indicator | TARA | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 62.46 |
| Support Level | $3.69 | $12.10 |
| Resistance Level | $4.23 | $18.40 |
| Average True Range (ATR) | 0.16 | 1.42 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 41.74 | 61.92 |
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.